N-(4-pyridyl)-4-(1-aminoethyl)cyclohexanecarboxamide,
Y 27632,
Y 27632, (4(R)-trans)-isomer,
Y 27632, (4(S)-trans)-isomer,
Y 27632, (trans)-isomer,
Y 27632, dihydrochloride, (4(R)-trans)-isomer,
Y-27632,
Y27632,
Y-27632 dihydrochloride,
129830-38-2,
Y-27632 2HCl,
Y-27632 (dihydrochloride),
Y 27632 dihydrochloride,
UNII-Q9828II7F3,
(1R,4r)-4-((R)-1-aminoethyl)-N-(pyridin-4-yl)cyclohexanecarboxamide dihydrochloride,
Y27632 2HCl,
Y27632,
Q9828II7F3,
Y 27632,
(1R,4r)-4-((R)-1-aminoethyl)-N-(pyridin-4-yl)cyclohexane-1-carboxamide dihydrochloride,
Y 27632 hydrochloride,
Y 27632 HCl,
138381-45-0,
(R)-(+)-trans-4-(1-Aminoethyl)-N-(4-Pyridyl)cyclohexanecarboxamide dihydrochloride,
cc-26,
C14H21N3O.2ClH,
SCHEMBL819701,
SCHEMBL819702,
CHEMBL536267,
CHEMBL1605605,
DTXSID3042635,
KS-00000XGM,
AOB3877,
EX-A423,
Tox21_500333,
ABP000260,
BS0207,
MFCD03490488,
AKOS024456492,
AKOS026673937,
CCG-100675,
CS-0878,
KIN0000327,
NCGC00092276-01,
NCGC00093773-01,
NCGC00261018-01,
BC600352,
HY-10583,
AB0033836,
FT-0771389,
S1049,
SW219086-1,
X7611,
Y-27632 dihydrochloride, >=98% (HPLC),
F10047,
F10064,
SR-00000001060,
J-005723,
SR-00000001060-1,
(r)-(+)-trans-N-(4-pyridyl)-4-(1-aminoethyl)-cyclohexanecarboxamide dihydrochloride,
4-[(1R)-1-aminoethyl]-N-pyridin-4-ylcyclohexane-1-carboxamide dihydrochloride,
Cyclohexanecarboxamide, 4-[(1R)-1-aminoethyl]-N-4-pyridinyl-, hydrochloride (1:2), trans-,
trans-4-((R)-1-aminoethyl)-N-(pyridin-4-yl)cyclohexanecarboxamide dihydrochloride,
trans-4-[(1R)-1-Aminoethyl]-N-4-pyridinylcyclohexanecarboxamide dihydrochloride,
trans-4-[(R)-1-Aminoethyl]-N-(4-pyridyl)cyclohexanecarboxamide dihydrochloride,
Trans-4-[(1R)-1-Aminoethyl]-N-4-pyridinylcyclohexanecarboxamide dihydrochloride (Y-27632 dihydrochloride),
y-27632,
C14-H21-N3-O.2Cl-H,
CID9901617,
146986-50-7,
A11001,
N-(4-Pyridyl)-4-(1-aminoethyl)cyclohexanecarboxamide dihydrochloride,
Y-27632 dihydrochloride, 98.5%, a selective ROCK1 (p160ROCK) inhibitor - 10MG 10mg,